The prevalence of cardiovascular disease in Ethiopia: a systematic review and meta-analysis of institutional and community-based studies.
Cardiovascular disease
Epidemiology
Ethiopia
Systematic review and meta-analysis
Journal
BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539
Informations de publication
Date de publication:
18 01 2021
18 01 2021
Historique:
received:
08
10
2019
accepted:
15
12
2020
entrez:
19
1
2021
pubmed:
20
1
2021
medline:
16
6
2021
Statut:
epublish
Résumé
Worldwide cardiovascular disease is the major cause of disability and premature death. This is due to the ascending trend of consuming an unhealthy diet and obesity which increases the risk of hypertension and type 2 diabetes mellitus. Thus this study aimed to determine the pooled prevalence of the cardiovascular disease in Ethiopia. Medline, Scopus, and Google Scholar search engines were accessed using medical subject heading (MeSH) terms for studies based in Ethiopia, from 2000 to 2018. However, studies done among a specific group of the population were excluded from the study. Data were extracted by one reviewer and then checked independently by a second reviewer. Studies were qualitatively synthesis in terms of design, quality, study population, outcomes, and result. Sub-group analysis and sensitivity tests were conducted to identify potential influences on the prevalence estimates. Quantitative results were pooled in a statistical meta-analysis using STATA version 14 software. Nine eligible cross-sectional studies were included in the analysis. The prevalence ranges from 1 to 20%. The pooled prevalence of cardiovascular disease (CVD) was 5% (95% CI: 3-8%). The prevalence was higher in the population who visits hospitals, 8% (95% CI: 4-12%) compared to the general population, 2% (95% CI: 1-5%). There was no significant difference in the overall prevalence of CVD between males and females. The prevalence of cardiovascular disease was high. A higher prevalence of CVD was found among patients who visited health institutions than the general population and no observed significant sex difference in the prevalence.
Sections du résumé
BACKGROUND
Worldwide cardiovascular disease is the major cause of disability and premature death. This is due to the ascending trend of consuming an unhealthy diet and obesity which increases the risk of hypertension and type 2 diabetes mellitus. Thus this study aimed to determine the pooled prevalence of the cardiovascular disease in Ethiopia.
METHODS
Medline, Scopus, and Google Scholar search engines were accessed using medical subject heading (MeSH) terms for studies based in Ethiopia, from 2000 to 2018. However, studies done among a specific group of the population were excluded from the study. Data were extracted by one reviewer and then checked independently by a second reviewer. Studies were qualitatively synthesis in terms of design, quality, study population, outcomes, and result. Sub-group analysis and sensitivity tests were conducted to identify potential influences on the prevalence estimates. Quantitative results were pooled in a statistical meta-analysis using STATA version 14 software.
RESULT
Nine eligible cross-sectional studies were included in the analysis. The prevalence ranges from 1 to 20%. The pooled prevalence of cardiovascular disease (CVD) was 5% (95% CI: 3-8%). The prevalence was higher in the population who visits hospitals, 8% (95% CI: 4-12%) compared to the general population, 2% (95% CI: 1-5%). There was no significant difference in the overall prevalence of CVD between males and females.
CONCLUSION
The prevalence of cardiovascular disease was high. A higher prevalence of CVD was found among patients who visited health institutions than the general population and no observed significant sex difference in the prevalence.
Identifiants
pubmed: 33461482
doi: 10.1186/s12872-020-01828-z
pii: 10.1186/s12872-020-01828-z
pmc: PMC7814574
doi:
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
37Références
J Am Heart Assoc. 2016 Feb 18;5(2):
pubmed: 26896477
Int J Cardiol. 2016 Oct 15;221:260-3
pubmed: 27404686
Cardiovasc J Afr. 2015 Mar-Apr;26(2 Suppl 1):S6-10
pubmed: 25962950
Cardiol Res Pract. 2016;2016:7147234
pubmed: 27974990
Trans R Soc Trop Med Hyg. 2009 May;103(5):461-8
pubmed: 19157475
Vasc Health Risk Manag. 2017 Apr 21;13:143-151
pubmed: 28461753
N Engl J Med. 1989 Sep 7;321(10):641-6
pubmed: 2488072
Circulation. 2011 Nov 8;124(19):2145-54
pubmed: 22064958
J Health Popul Nutr. 2014 Mar;32(1):1-13
pubmed: 24847587
J Neurol Sci. 2015 Aug 15;355(1-2):138-42
pubmed: 26059446
J Cardiovasc Dev Dis. 2019 Apr 27;6(2):
pubmed: 31035613
Arch Intern Med. 2009 Oct 26;169(19):1762-6
pubmed: 19858433
PLoS One. 2018 May 9;13(5):e0194819
pubmed: 29742131
Heart. 2015 Sep;101(17):1389-94
pubmed: 26076935
J Trop Pediatr. 2013 Oct;59(5):350-7
pubmed: 23644695
J Clin Epidemiol. 2012 Sep;65(9):934-9
pubmed: 22742910
Circulation. 2015 Oct 27;132(17):1667-78
pubmed: 26503749
BMC Public Health. 2018 Jun 20;18(1):778
pubmed: 29925336
BMC Health Serv Res. 2018 Jul 4;18(1):520
pubmed: 29973219
Arch Cardiovasc Dis. 2012 Feb;105(2):77-83
pubmed: 22424325
BMJ Open. 2017 Oct 22;7(10):e015496
pubmed: 29061601
Eur J Prev Cardiol. 2017 May;24(7):717-723
pubmed: 28071960